Difference between revisions of "Ber-EP4"
Jump to navigation
Jump to search
(create) |
(No difference)
|
Revision as of 16:21, 15 May 2016
Ber-EP4 is a commonly available immunostain.
Positive
- Basal cell carcinoma.
- Lung adenocarcinoma (55 of 59 cases[1]).
Negative
- Squmous cell carcinoma of the skin.
- Malignant mesothelioma (18 of 70 cases[1]).